Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Treatment with our candidate lead ferroptosis inhibitor, UAMC-3203, strongly delays relapse and ameliorates disease progression in a preclinical model of relapsing-remitting MS
Among type 2 diabetic patients with or without AD who were treated with GLP-1RAs, no differences were seen in the risks for mortality, new-onset MACE, MI, heart failure, or stroke
The Lasker~Koshland Special Achievement Award in Medical Science was jointly awarded to Professors Quarraisha Abdool Karim and Salim Abdool Karim of Columbia University
This compound is part of a class of GLP-1 receptor agonists, which have gained attention for their ability to improve insulin sensitivity and regulate appetite
US$ 24.69
US$ 27.37
US$ 29.74
US$ 28.42
US$ 21.12
